Pankaine Spinal Heavy (Bupivacaine Hydrochloride, Anhydrous)

Bupivacaine hydrochloride is employed in regional anesthesia to achieve profound nerve blockade for surgical and obstetric procedures.

• Cesarean section: provides long‑lasting analgesia for mother and newborn safety.
• Orthopedic surgery: enables extended postoperative pain control after joint and limb operations.
• Lower limb vascular surgery: offers sustained sensory block for procedures on the femoral or popliteal vessels.
• Chronic pain management: used in epidural infusions for refractory cancer or neuropathic pain.
• Urological ‑ procedures: facilitates pain‑free cystoscopy and transurethral resections.
• Gynecologic surgery: supports analgesia during hysterectomy and laparoscopic procedures.

• Bupivacaine blocks voltage‑gated sodium channels on neuronal membranes, stabilising the neuronal membrane and preventing the initiation and propagation of action potentials. This inhibition of sodium influx halts nerve impulse transmission, producing reversible loss of sensation and motor function in the targeted region.

Bupivacaine may cause a range of adverse reactions, from mild to severe, depending on dose and administration site.

Common Side Effects

• Transient tingling or numbness at the injection site.
• Mild hypotension due to sympathetic blockade.
• Headache, often post‑dural puncture.
• Nausea or vomiting.
• Temporary urinary retention.

Serious or Rare Side Effects

• Cardiovascular toxicity, including arrhythmias or cardiac arrest.
• Central nervous system toxicity such as seizures.
• Persistent motor block lasting beyond the expected duration.
• Allergic reactions ranging from rash to anaphylaxis.
• Methemoglobinemia.
• Spinal hematoma or infection at the injection site.

When using Bupivacaine for spinal anesthesia, clinicians should assess patient risk factors and monitor closely.

• Cardiac monitoring: observe for arrhythmias, especially in high‑dose cases.
• Neurological assessment: check motor and sensory function regularly.
• Dose limitation: adhere to recommended maximum doses to avoid systemic toxicity.
• Contra‑indications: avoid in patients with known hypersensitivity to amide‑type local anesthetics.
• Pregnancy: use only when benefit outweighs potential fetal risk.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Bupivacaine may interact with other agents that influence cardiac conduction or central nervous system activity.

Major Interactions (Avoid)

• Class I anti‑arrhythmic drugs (e.g., quinidine, procainamide): increased risk of cardiotoxicity.
• Beta‑blockers combined with high‑dose Bupivacaine: potentiates bradycardia and hypotension.
• CNS depressants (e.g., benzodiazepines, opioids): may enhance neurotoxicity.

Moderate Interactions (Monitor Closely)

• Calcium channel blockers: may augment hypotensive effects.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential for additive renal effects.
• Magnesium sulfate: can increase neuromuscular blockade.
• Lithium: heightened risk of neuro‑excitatory toxicity.
• MAO inhibitors: may modify plasma levels of Bupivacaine.